Despite being a potentially critical antioxidant, not much is known about the acute effects of CS on the GSH adaptive response and how GSH levels can fluctuate both during and between CS exposures especially in the lung ELF
A loading phase of 1mg three times weekly for two weeks, then maintenance of 1mg every two to three months, adjusted for the cause and any neurological involvement
Administration less frequent than twice weekly likely allows complete dissipation of synaptic changes between doses, preventing the cumulative structural modifications that constitute Dihexas therapeutic mechanism
267 discovered many cytokines that stimulate activating phosphorylation of PGC-1 through p38 MAPK pathway, ultimately resulting in heightened respiration and energy expenditure in muscle cells
Chlorzoxazone, a selective probe for phenotyping CYP2E1 in humans
DSIP (Delta Sleep-Inducing Peptide) was first identified during investigations of endogenous peptide signaling systems and subsequently isolated as a distinct neuropeptide